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Abstract
Francisella tularensis is the causative agent of the human disease tularemia. It is highly infectious
with as few as 10 microorganisms via inhalation causing a lethal infection. F. tularensis infects a
variety of cell types, including macrophages and neutrophils, since it needs to enter, survive and
proliferate in order to cause pathogenicity. Disease is the result of over activating the host’s own
inflammatory response initiated by the macrophage’s response to infection.
Known differences exist in the intensity of the inflammatory response between the sexes which
leads to differences in sensitivity to autoimmune and infectious disease. Males tend to be more
susceptible to infectious diseases whereas females tend to be more susceptible to autoimmune
diseases. In contrast, our preliminary data demonstrated that female mice were more susceptible
than male mice to the infectious disease F. tularensis.
We hypothesized that female macrophages respond to F. tularensis infection by generating a
more intense inflammatory response which makes females more susceptible to F. tularensis
disease. We determined the relative ratio of M1/M2 subtypes in vivo and their subsequent response
to F. tularensis infection in vivo and ex vivo. Splenic macrophages were isolated and differentiated
in vitro into M1 and M2 subtypes in order to directly compare differences in the intracellular
response between males and females in response to F. tularensis infection. Our results
demonstrated that females possess a higher abundance of M1 macrophages and that these M1
macrophages are more inflammatory in response to F. tularensis infection.
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Chapter 1: Introduction
1.1 Francisella tularensis and Tularemia disease
Francisella tularensis, the causative agent of tularemia, is highly contagious and can
cause human infections with as few as 10 microorganisms via the inhalation route [1-4]. F.
tularensis is a gram-negative intracellular coccobacillus and is categorized as a tier 1 select
agent by the Centers for Disease and Control and Prevention (CDC) and category A pathogen
by the National Institutes of Health (NIH) [1]. Select agents have the potential to be a major
public health problem causing severe disease and lethality [5]. Select agents also include
agents of viral hemorrhagic fevers such as filoviruses (Ebola, Marburg), Bacillus anthracis
(anthrax), Yersinia pestis (plague) and more highly dangerous pathogens [6].
There are four strains of F. tularensis of significant public health import, subspecies
(subsp.) tularensis, holartica, novicida and mediasiatica. F. tularensis subsp. tularensis (type
A) is the most commonly acquired in North America and the most highly virulent for
humans. It persistently infects many small mammals, including domestic animals like cats
and rabbits, from which it can be transferred to humans. F. tularensis subsp. tularensis is
estimated to cause 70% of tularemia clinical cases in humans in North America [7, 8]. The
disease has been reported in all states in the United States except for Hawaii [9, 10].
Infections in Arkansas, Oklahoma and Missouri account for approximately 50% of the cases
of tularemia reported in the US each year (Figure 1) [9, 10].
Type B strains, primarily found in Europe and Asia, e.g., F. tularensis subsp. holarctica,
are less virulent, due to its slower dissemination and cause a milder form of the disease than
subsp. tularensis [5]. Type B is associated with semiaquatic rodents such as muskrats and
beaver in North America and, therefore, is rarely transmitted to humans with the decline of
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trapping of these animals. A live attenuated vaccine was developed in 1942 called F.
tularensis live vaccine strain (LVS) [5]. LVS was derived from F. tularensis subsp.
holarctica and has shown some efficacy in humans and in animal models. However, LVS is
not licensed for general human use and is restricted to military personnel and first
responders [11].

Figure 1. reported case of tularemia in the United States [12].

F. tularensis infection is transmitted through multiple routes (Figure 2): 1) handling the
carcass of an infected animal; 2) the bite of an infected arthropod vector such as a tick, deer
fly or flea; 3) ingesting meat from a contaminated animal; 4) drinking contaminated water;
and, 5) inhalation of aerosol droplets, which causes the most severe disease. Since close
contact with infected animals is required for the majority of transmissions, tularemia
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infection commonly occurs during summer in the south-central US due to the high exposure
to infected ticks. In the northeastern US, infection peaks during winter due to the hunting
season. The incident of disease is dramatically increased when a warm winter is followed by
a wet summer causing the tick population to proliferate [9, 13, 14].
Ticks are the most common vector for arthropod-mediated tularemia transmission in the
United States while mosquito-mediated transmission is most common in Europe. Tick
transmission is more frequently associated with type A strains than type B strains. Ixodes,
Dermancentor, and Ambylomma tick species transmit tularemia to humans and are present
throughout the states, including Texas [9, 15]. Type B strains have been isolated from
streams, ponds, lakes and rivers, from which the disease can be spread by drinking
contaminated water. F. tularensis can survive in water and animal carcasses for long periods
[5, 9]. Aerosol transmission has been documented as a result of mowing lawns or working on
farms due to the prolonged survival of F. tularensis in the soil after death of an infected
animal [9, 14, 15].
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Figure 2. Transmission of Francisella tularensis [16].

There are six major clinical manifestations related to primary site of the infection (Figure
3). Ulceroglandular, which is the most common, starts as a painful papule at the site of the
infection, such as a tick bite or direct inoculation of the bacteria into the skin, which later
becomes an ulcer. Glandular tularemia is similar to ulceroglandular, but without an ulcer, and
can also develop from the bite of a tick, deer fly or from handling sick or deceased animals
[9, 17]. Oropharyngeal tularemia is characterized by swelling of lymph glands in the neck
and is caused from eating contaminated food or drinking contaminated water. Oculoglandular
4

tularemia is acquired when a person touches the eyes with infected fingers or contaminated
water gets in the eyes and develops as painful conjunctivitis and swelling of lymph glands in
front of the ear. Typhoidal tularemia results from ingestion or inhalation of the bacteria
causing very serious side effects, e.g., septic shock, with hepatomegaly and splenomegaly
usually apparent. Pneumonic tularemia results from inhalation of aerosolized bacteria and is
the most severe manifestation of tularemia due to the high mortality rate (>30% if untreated).

Figure 3. Clinical symptoms of tularemia, top left: ulceroglandular [18], bottom left:
oculoglandular [19] and right: glandular tularemia panel [19].

Tularemia is primarily treated with the antibiotics gentamicin, streptomycin, doxycycline or
ciprofloxacin. However, they must be given immediately following exposure and for prolonged
time; the treatment with antibiotics usually lasts 10 to 21 days [9, 17]. Despite the necessary
rapid response, pneumonic tularemia is often misdiagnosed thereby delaying treatment.
Furthermore, we do not fully understood factors that influence susceptibility to tularemia.
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1.2 Mechanism of Francisella tularensis pathogenesis
F. tularensis is a cytosol-dwelling pathogen that needs to enter, survive and proliferate in
order to cause pathogenicity [20]. It infects a variety of host cells, including macrophages,
dendritic cells (DC), polymorphonuclear neutrophils, hepatocytes, endothelial, and type II
alveolar lung epithelial cells [21].
F. tularensis binds to various immune receptors, such as the mannose receptor cluster of
differentiation 206 (CD206), complement receptor 3 (CR3) consisting of (CD11b), the
scavenger receptor-A (SR-A), and Fc receptors (CD16/32), triggering phagocytosis [22, 23].
Among those receptors, Fc receptors are the main phagocytic receptors involved during
uptake of F. tularensis [22]. Following uptake, the bacterium will reside within the
phagosome, called the Francisella-containing phagosome (FCP) [20]. The FCP sequentially
acquires markers of early and late endosomes such as early endosome antigen 1 (EEA-1),
CD63, lysosomal associated membrane protein 1 (LAMP-1), LAMP-2 and Rab7 [24]. The
acquisition of these markers suggest that the FCP are subject to maturation into a bactericidal
phagolysosome. However, the FCP does not fuse with lysosomes; instead, the bacterium
physically disrupts the phagosomal membrane and escapes into the host cell cytosol [25].
This phagosomal escape is dependent on MglA, a master transcription factor, and is critical
for intracellular survival and proliferation [24]. Indeed, F. tularensis mutants deficient in the
MglA gene product do not survive inside the cell and do not cause pathogenesis. F. tularensis
achieves phagosomal escape by expressing a type VI-like secretion system that helps in
disrupting the phagosomal membrane [26]. Other factors also help in the phagosomal exit
such as acid phosphatases and pyrimidine biosynthetic genes [27, 28].
The presence of F. tularensis in the cytosol of macrophages is recognized by innate
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pattern-recognition receptors (PRRs) such as the Nod-like receptors (NLRs), NLRP3 and
interferon-inducible protein 2 (AIM2) [20]. PRRs recognize pathogen-associated molecular
patterns (PAMP) or danger-associated molecular patterns (DAMP) to initiate the innate
immune response [29]. Recognition of cytosolic F. tularensis by the PRRs, NLRP3 or AIM2
results in formation of the multiprotein complex, the inflammasome, which initiates
inflammation. Once activated, the inflammasome matures the precursor of the proinflammatory cytokines interleukin-1 (IL-1) and IL-18 [30]. Following secretion, these in
turn initiate a cascade of inflammatory cytokine production from neighboring cells.
The continued production of these inflammatory cytokines results in an imbalance in the
immune response, called a cytokine storm. This overproduction of inflammatory plus
dysregulated anti-inflammatory cytokines causes severe side effects such as edema,
hypovolemia, pneumonia and death. As such, F. tularensis is part of a small but deadly class
of pathogens that cause disease by triggering an overactive pro-inflammatory immune
response rather than excessive replication of the F. tularensis bacteria or production of
bacterial toxins [31].
This cytokine storm includes the overproduction of a number of cytokines, including
Interferon (IFN)- , IL-6, and tumor necrosis factor- (TNF-). IFN- is a potent
macrophage activating factor inducing anti-LVS activity in resident peritoneal macrophages
infected with F. tularensis [32]. Activated macrophages have many potential antimicrobial
effector activities not present in resting macrophages, including downregulation of transferrin
receptors for decreasing intracellular ion, degradation of tryptophan, and production of
effector molecules such as reactive oxygen and nitrogen intermediates [33].
Recombinant IFN- stimulates both resident and inflammatory macrophages to inhibit
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bacterial growth in dose-dependent manner [32]. Interestingly, resident macrophages
required higher concentrations of IFN- for bacterial growth inhibition than do inflammatory
macrophages [32]. In addition, nitric oxide (NO) production by activated macrophages
correlates directly with killing a variety of infectious targets in murine systems, including F.
tularensis, and is a quantitative index of macrophage activation and killing capacity [32].
IFN--activated macrophages kill a number of intracellular and extracellular targets;
however, this effector function can be altered by the nature of the macrophage population
[34]. Classically-activated M1 type macrophages are induced by IFN- and
lipopolysaccharide (LPS) and are readily identified by the presence of the surface marker
CD80 [35, 36]. M1 type macrophages secrete pro-inflammatory cytokines, including TNF-
and IL-1, and serve immunostimulatory functions including elimination of intracellular
microbes and induction of the T helper 1 (Th1) response [35]. Alternatively-activated M2
type macrophages are activated by IL-4, IL-10, or immune complexes to secrete antiinflammatory cytokines, such as transforming growth factor  (TGF-), and display
heterogeneous surface markers including CD163, CD200R, and CD206 [37] . M2 type
macrophage functions are anti-inflammatory or pro-resolving in nature and include debris
clearance, matrix remodeling and tissue repair [38].
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1.3 Sex differences in immune response
The production of inflammatory cytokines contributes to infection resistance by making
the host environment less suitable causing undesirable symptoms such as fever, swelling,
vomiting [39]. However, in the case of tularemia, the overproduction of these same
inflammatory cytokines adversely affects the host itself, ultimately causing disease and
death. Therefore, the intensity of inflammation is directly tied to survival from F. tularensis
infection.
Host immunity plays a key role in defining resistance and susceptibility to infection [40].
Differences in the intensity of the inflammatory response have been observed between male
and female immune responses. These differences in intensity of the immune response
between the sexes leads to differences in sensitivity to autoimmune and infectious diseases
[40-42]. Males tend to be more susceptible to infectious disease whereas females tend to be
more susceptible to autoimmune disease.
Differences between the male and female immune response to bacterial infections have
been noted at various levels. In addition to a marked difference between males and females in
B cell activity and antibody production in response to bacterial infection, there are also
differences between frequency, severity, and outcome of severe sepsis and septic shock [43].
Sex based differences have been observed in animal studies in susceptibility to
Mycobacterium marinum infection in mice where males showed higher disease severity,
bacterial burden and mortality than female mice [43, 44]. Similarly, rats administered Vibrio
vulnificus-derived lipopolysaccharide (LPS) led to endotoxic shock in male rats, causing a
mortality rate of 82%, while females exhibited only a 21% mortality rate [43, 45].
Interestingly, female sepsis patients exhibit higher levels of the anti-inflammatory cytokine
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IL-10 than do age and disease severity matched male patients [43, 46]. In another study,
Escherichia coli-derived LPS administration in mice elicited higher circulating levels of
interleukin-6 (IL-6) in male than in female mice. Taken together, prevailing data suggests
that females are less susceptible to the development of bacterial infection and subsequent
bacteremia and/or sepsis while males exhibit greater incidence and severity of bacterial
infections and are far more likely to develop lethal sequelae [43]. In the case of F. tularensis,
while cases are more frequent in males than females, the frequency of exposure is also likely
higher in males due to non-biological gender differences between males and females, such as
increased risk behavior for infection [47].
Females produce stronger cellular and humoral immune reactions which may result in a
higher incidence of autoimmune diseases, such as multiple sclerosis (MS), atherosclerosis,
arthritis, systemic lupus erythematosus and insulin-dependent diabetes mellitus as compared
to males [40, 48-50]. These differences in susceptibility may be caused by differences in
immune responses between the sexes and/or their reproductive phases which are
accompanied by variations in sex hormones, as is the case where estrogens increases
antibody production [50]. In contrast, males are more susceptible to infections because of
behaviors that make them more suitable to acquisition of the infection and their sex steroid
hormones that can affect resistance genes [40].
There are also differences between cell-mediated immune responses between the sexes.
Reliance on subsets of helper T cells (Th1 or Th2) varies between sexes where
females exhibit higher Th2 responses, such as higher interleukin (IL) production of IL-4, IL5, IL-6 and IL-10 than males. Consequently, females of many species might produce elevated
immune responses even against self-tissues and develop autoimmune diseases as compared

10

to males [40].
Hormones, such as estrogens, generally enhance both cell-mediated and humoral immune
responses and can modulate immune function in females that might contribute to resistance
against infection. Sex steroids circulating in the body can alter the immune system by
influencing the survival or death of cells and lymphocytes as well as differentiation of
activated immune cells. Sex steroid hormones modify major histocompatibility complex
(MHC) class II expression on antigen presenting cells (APCs). APCs from female mice are
more efficient at presenting peptides than are APCs from males suggesting that MHC
expression may be different between the sexes. In addition, castration of males increases
antigen presentation by immune cells and testosterone-treatment of females decreases antigen
presentation [40].
In addition, sex differences in the production of pro-inflammatory cytokines and
chemokines have been documented following in vitro LPS challenge of isolated rodent
peripheral monocytes and macrophages [43]. In vitro studies using peritoneal macrophages
show that cells derived from young male mice produce higher levels of IL-1 and IL-6
following LPS challenge than do similarly treated cells derived from females [43]. However,
these results are contradicted by another study in which peripheral monocytes from female
mice produced more IL-6 than monocytes from males, even though these same cells from
females produced less TNF-  than males cells did [43]. Another study demonstrated that
female-derived splenic macrophages secreted higher levels of the anti-inflammatory cytokine
IL-10 than did cells derived from males [51]. Therefore, conflicting results from previous
reports cannot solely be used to prove/disprove our hypothesis.
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Chapter 2: Preliminary Data
2.1 Evaluation of survival in male and female mice
Male and female C57BL/6 mice were inoculated intradermally with 8e5 colony forming
units (CFU) of live vaccine strain (LVS) bacteria. The LVS infection was monitored over the
course of two weeks. Female mice were more sensitive to F. tularensis infection than male mice
(Figure 4). This difference could be explained by one of 3 possibilities: 1) differences in bacterial
burdens between males and females, 2) differential susceptibility due to production of different
sex hormones, 3) differences in the immune response to the bacterium. i.e., the cytokine storm.

P e rc e n t s u rv iv a l

100

p < 0 .0 0 1
50

M a le , n = 1 0
F e m a le , n = 1 0
0
0

5

10

15

D a y s p o s t i n fe c t io n

Figure 4. Male and female C57BL/6 mice were infected intradermally with 8e5 cfu of F.
tularensis LVS bacteria and infection was monitored by weighting the animals daily over the
course of 2 weeks. (N=10). Significant difference (p<0.001, Mantel-Cox test) between male and
female.

2.2 Bacterial burden in target organs
The first possibility is that the bacterial burden may be higher in females causing more
severe symptoms leading to death. Spleen, liver and lung organs were harvested from infected
mice and bacterial burden was determined during the course of the infection in order to compare
bacterial growth in each sex. No difference in bacterial growth was observed (Figure 5).
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Figure 5. Male and female C57BL/6 mice were infected with 1e6 cfu of F. tularensis LVS
intradermally and organs were harvested 3 days post-inoculation. Bacterial load was determined
during the course of infection with LVS. No significant differences were detectable by ANOVA
(n=4 mice per time point).

2.3 Differential susceptibility due to sex hormones
As described in 1.3, the immune system responds to sex hormones. Therefore, to
determine their role in this sex difference, the gonads were removed in young mice in order to
deplete the sex hormones. Both males and females without gonads were more susceptible to F.
tularensis infection compared with intact animals (Figure 6). However, removal of the sex
hormones did not alter the dichotomy observed in the intact animals.
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Figure 6. In male and female C57BL/6 young mice, gonads were removed. Then male and
female mice were infected with 8e5 cfu of F. tularensis LVS and percent survival was observed
over the course of two weeks from intact and gonadectomized mice. Significant differences
(p<0.0006, Mantel-Cox test) between wild type and gonads mice and between the sexes within
each group.
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2.4 Cytokine storm analyzed by multiplex ELISA assay
In order to determine whether differences in the immune response may explain the sex
difference observed in outcome, we quantified the serum levels of 19 cytokines in each mouse
over time on an individual basis. Out of the 19 cytokines analyzed, five pro-inflammatory
cytokines and the anti-inflammatory cytokine IL-10 showed a temporal response to the infection.
Overall female mice had higher serum levels than male mice of all these cytokines, indicating a
more intense cytokine storm (Figure 7). Therefore, we hypothesized that immune cells
responding to infection, may be responsible for this difference in susceptibility between the
sexes.
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Figure 7. Male and female C57BL/6 mice were infected with 1e6 cfu of F. tularensis LVS
intradermally and blood was collected at days 0, 3 and 5 post-infection and at the time of
termination (T). Serum was analyzed by Milliplex quantifying 19 different cytokines in each
mouse over time on an individual basis. Significant differences were observed (p<0.005, twoway ANOVA, n=4-10) between the main effect (sex) of the following analytes: IL-6,IL-1, IL10 and TNF-.
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2.5 Myeloid growth and differentiation factors
In addition, during the analysis of serum cytokines, growth, differentiation and
chemotactic factors were also measured after challenge with F. tularensis before inoculation, at
days 3 and 5 after inoculation and at termination. Female mice had also higher serum levels
specifically of myeloid growth and differentiation factors compared with male mice (Figure 8),
suggesting a role specifically for myeloid cells in this alteration in the immune response.
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Figure 8. Male and female C57BL/6 mice were infected with 1e6 cfu of F. tularensis LVS
intradermally. Blood was collected at day 0, 3 and 5 post-infection and at the time of termination
(T). Serum was analyzed by Milliplex quantifying myeloid growth and differentiation factors in
each mouse over time on an individual basis. Significant differences were observed (P<0.05,
two-way ANOVA, n=4-10) between the main effect (sex) of the following analytes: MIP-1,
MIP-1 and MIP-2.
2.6 Hypothesis
Despite F. tularensis being an infectious disease, it causes disease much as an autoimmune
disorder with an imbalance in inflammation in females. Therefore, we hypothesized that female
macrophages respond to F. tularensis infection by generating a more intense inflammatory
response which makes females more susceptible to F. tularensis disease.
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2.7 Specific Aims and Approach
Based on the preliminary data in Chapter 2, we proposed to test our hypothesis that the female
inflammatory response makes them more susceptible to F. tularensis disease through:
Aim 1: Profiling male and female immune cells after infection with F. tularensis.
1a) Analyze immune cells responding to infection by flow cytometry.
1b) Determine differences in the presence of inflammatory and regulatory macrophages
between males and females.
1c) Analyze the temporal activation of macrophages in males and females.
1d) Analyze cytokine and chemokine responses of males and females responding to
infection.
Aim 2: Identify the mechanisms by which macrophages control susceptibility to F. tularensis.
2a) Determine the relative percentages of M1 vs M2 macrophages in males and females.
2b) Compare the cellular response of M1 and M2 macrophages between males and
females.
2c) Analyzing the different signaling pathways activated in males and females.
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Chapter 3: Materials and methods
3.1 Reagents
The antibodies used for flow cytometry assay are; FITC-labeled anti-CD80 (Tonbo biosciences),
PE-Cy7-labeled anti-CD23 (BD biosciences), APC-labeled anti-CD11b (Tonbo biosciences),
PACB-labeled anti-CD11b (Tonbo biosciences),PE-CF594-labeled anti-CD45R/B220 (BD
biosciences), CD16/CD32 (Fc shield) (Tonbo biosciences), APC-labeled anti-LY6G (BD
biosciences), Alexa flour 700-labeled anti-LY6C(Bio legend) and PE-labeled anti-IL-6 (BD
biosciences). Pac Blue-labeled anti-CD11b (Biolegend), PERCP-labeled anti-siglec F (BD
biosciences), PECY7-labeled anti-CD23 (BD biosciences), APC-labeled anti-CD3e (TONBO),
APC-CY7-labeled anti-LY6G (BD biosciences), Alexa flour 700-labeled anti-LY6C(BD
biosciences), FITC-labeled anti-iNOS (eBioscience), PE-labeled anti-Arginase (eBioscience),
Cytofix/Cytoperm (BD biosciences),Ciprofloxacin 500 g /ml (Sigma) and gentamicin 50 mg/ml
(Fisher) will be used to grow macrophages and bacteria, respectively. Mueller-Hinton agar plates
supplemented with 1% IsoVitaleX enrichment (BD biosciences), 5% defibrinated sheep blood
(Quad five) and 10% glucose (Sigma) will be used to grow bacteria. Red Blood cells (RBC) lysis
buffer (0.83% ammonium chloride, 0.1% potassium bicarbonate, 0.04% EDTA, pH 7.4), FACS
buffer (4% inactivated FBS (Hyclone) and 0.4% 2 mM EDTA in 1X PBS (Fisher)).
Cytofix/Cytoperm plus kit (BD Biosciences) for internal staining. Invitrogen IL-6 mouse kit
(Thermo Fisher), Invitrogen IL-10 mouse kit (Thermo Fisher) will measure responses to
bacterial infection. Macrophages will be grown in Dulbecco’s modified Eagles’ medium
(DMEM) (Corning) supplemented with 10% inactivated FBS, 1% glutamine (Hyclone) and 1%
Amphotericin B (Hyclone).1% penicillin/streptomycin (Lonza), RNeasy plus mini kit (Qiagen).
LPS (100ng/mL, Sigma-Aldrich L2880), IFN- (20ng/mL, eBioscience), IL-4 (20ng/mL,
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eBioscience). CYBRFast 1-step RT-qPCR HI-ROX Kit (Tonbo). iNOS, GAPDH and CD206
primers (Sigma). Diphtheria toxin from Corynebacterium (1 mg, Sigma Aldrich). Vacuum
manifold for 96 well filter plates (abcam), BCA protein Assay kit (Thermo), Protease inhibitor
cocktail (Sigma), 9-plex Multi-Pathway Total Magnetic Bead Kit (Millipore), 9-Plex MultiPathway Signaling Mag Bead Kit-Phosphoprotein (Millipore), Mouse Cytokine/Chemokine
Magnetic Bead Panel (Millipore), heparinized capillary tubes (Fisher).
3.2 Bacteria culture
F. tularensis holarctica LVS was obtained from Stanford University and grown on MuellerHinton plates supplemented with 1% of IsoVitaleX, plus 5% defibrinated sheep blood, at 37 C
for 2 days. After the second day of incubation, bacteria were scrapped into 15% glycerol in PBS,
aliquoted and stored at -80C until further use.
3.3 Mouse infections
Female and male C57BL/6 mice and CD11b-hDTR mice (6 to 8 weeks old) were purchased
from Jackson Laboratories, breed and maintained at UTEP’s animal facility following OLAW
guidance and animal protocol (A-201809-1) approved by UTEP’s Institutional Animal Care and
Use Committee (IACUC). For injection, bacterial stocks were diluted to the indicated
concentration in sterile PBS. Mice anesthetized with 3-5% isoflurane inhalation were injected
intradermally in the flank above the hind quarters with 50 ul of 8e5 – 1e6 cfu bacteria.CD11bhDTR mice injection diphtheria toxin was diluted to the indicated concentration in sterile PBS.
Mice anesthetized with 3-5% isoflurane inhalation were injected peritoneally into the peritoneal
cavity with 15ng/g/day of diphtheria toxin. Animals were monitored every 12 hours postinfection for the first 48 hours, and every 8 hours thereafter. All animals were weighed before
inoculation and every morning thereafter. An animal was considered terminal and humanely
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euthanized per AVMA standards when it had lost 20% of its baseline weight. In addition,
animals were checked for clinical symptoms of disease and considered terminal when lethargic
and immobile with prodding.
3.4 Mouse retro-orbital blood collection
During infection course, blood was collected every other day through retro-orbital route
alternating the eyes. Approximately 40 L of blood was collected into heparinized capillary
tubes and transferred to a 1.5 mL microcentrifuge tube. Blood samples were centrifuged at 1000x
g for 10 minutes at 4°C. Plasma was transferred to a new microcentrifuge tube and stored at 80°C for future analysis for cytokine storm.
3.5 Milliplex Assay for cytokine storm
Collected plasma samples were analyzed using Mouse Cytokine/Chemokine Magnetic Bead
Panel kit following the manufacture’s protocol. Plates were read on MAGPIX with xPONENT
software.
3.6 Macrophage Polarization
Mice were euthanized in a CO2 chamber followed by cervical dislocation. Spleens were
harvested from male and female mice and homogenized by passage through a 70 m cell
strainer, then centrifuged for 10 min. Red Blood Cells (RBC) were lysed with RBC lysis buffer
and lymphocytes distributed into Dulbecco’s modified Eagles’ medium (DMEM) supplemented
with 10% inactivated FBS, 1% glutamine,1% Amphotericin B, 1% penicillin and 10% of L929
growth factor and placed into T-75 flasks (Falcon). The next day, media was replaced with
media containing either LPS+ IFN- (M1) or IL-4 (M2) but without L929 growth factor for
polarization purposes; media was left overnight. The next day splenocytes were passaged and
5e5 macrophages seeded per well into 96-well plate with Dulbecco’s modified Eagles’ medium
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(DMEM) supplemented with 10% inactivated FBS, 1% glutamine and 1% Amphotericin B and
left overnight.
3.7 Macrophage infection
Splenocytes were infected with 1e10 colony-forming unit (cfu) of F. tularensis holarctica LVS
(a multiplicity of infection (MOI) of 30) in DMEM supplemented with 10% inactivated FBS, 1%
glutamine and 1% Amphotericin B for 2 hours. Once the 2 hours period of incubation were done,
the cell growth media was removed and 3 washes with 1X PBS were performed and replaced
with gentamicin (0.1μg/mL) was administered for 1 hour and 30 minutes. Media was removed
and replaced after time point with media containing gentamicin at a lower dose (0.01μg/mL) and
plate was incubated at 37°C, in 5% CO2 atmosphere for 24 hours. After 24 hours of incubation,
100 ul of supernatant was collected and placed at -20C until further analysis. Supernatant was
replaced with 100 ul of DMEM supplemented with 10% inactivated FBS, 1% glutamine and 1%
Amphotericin B and the plate was incubated for another 24 hours. After 48 hours of incubation,
100ul of supernatant was collected and placed at -20C.
3.8 Enzyme Linked ImmunoSorbent Assay
Collected supernatants were analyzed using the Invitrogen IL-6 kit and IL-10 kit following the
manufacture’s protocol.
3.9 RNA extraction
After supernatant was collected after 48 hrs, cells attached to 96 well plate were detached with
trypsin 0.05% incubation at 37°C, in 5% CO2 atmosphere for 2 minutes or until all the cells
detached from the bottom. Once the cells were detached trypsin was neutralized with DMEM
supplemented with 10% inactivated FBS, 1% glutamine and 1% Amphotericin B, and transferred
to a microcentrifuge of 1.5 mL and centrifuged for 10 min at 1500 rpm. Supernatant was
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removed and the cell pellet was processed for RNA extraction following manufacture’s protocol
for RNeasy plus mini kit extraction. Once the RNA was obtained for each sample, it was
quantified by absorbance using the NanodropTM Spectrophotometer. Samples were stored at the 80C until further analysis.
3.10 Real-time RT-PCR
Master mix was made, containing RTase 1 μL, CYBRFast 10 μL (Tonbo Bio), 1 µM each of
forward and reverse of target primer for each reaction. Another master mix was made, containing
RNA sample (10 ng) and RNA-free water for each sample. Both master mixes were added to an
Optical quality 96-well PCR plate (Applied Biosystems). Negative controls contained master
mix and just RNA-free water. PCR plate was run following lab’s protocol on StepOne Plus
(Applied Biosystems).
3.11 Flow cytometry
Mice were euthanized in a CO2 chamber followed by cervical dislocation. Spleens were
harvested from male and female mice and homogenized by passage through a 70 m cell
strainer, then centrifuged for 10 min. Red Blood Cells (RBC) were lysed with RBC lysis buffer
and lymphocytes distributed into Dulbecco’s modified Eagles’ medium (DMEM) supplemented
with 10% inactivated FBS, 1% glutamine, 1% Amphotericin B, 1% penicillin and then 200L of
each cell suspension was added to a 96 wells plate. Fc receptors were neutralized with FC shield
(Tonbo Bio) for 15 min at 4°C. After incubation, buffer was removed and fluorochrome
conjugated antibodies were added at 0.5 µg/1e6 cells: PE-CF594-labeled anti-CD45R, Pac Bluelabeled anti-CD11b, PERCP-labeled anti-siglec F, PECY7-labeled anti-CD23, APC-labeled antiCD3e, APC-CY7-labeled anti-LY6G, Alexa flour 700-labeled anti-LY6C and incubated for 20
min at 4°C. For the control standard, 1 ul of a single antibody was added to the cells. After
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incubation, cell suspensions were centrifuged, and the buffer was removed. Cells were perm
wash and fixed using Cytofix/Cytoperm kit to stain intracellular with FITC-labeled anti-iNOS
PE-labeled anti-Arginase. The cell suspension was resuspended in Dulbecco’s modified Eagle’s
medium without phenol red (DMEM) and enriched with 5% FBS and 1% Penicillin/streptomycin
(Lonza) and passed through a 70 m cell strainer and collected in 5 ml conical tubes to analyze
with Beckman Coulter Gallios Flow Cytometer.
3.12 BCA Protein assay
Macrophages were polarized and infected in step 3.4 and 3.5, following infection media was
removed and 9-plex Multi-Pathway Total Magnetic Bead Kit and 9-Plex Multi-Pathway
Signaling Mag Bead Kit-Phosphoprotein was used following the manufacture’s
recommendations. Shortly lysis buffer was added to the controls and infected wells, protein
concentration was measure using BCA protein assay following manufacture’s protocol.
3.13 Milliplex for Multi-pathways Assay
Collected cell lysates were analyzed using 9-plex Multi-Pathway Total Magnetic Bead Kit and 9Plex Multi-Pathway Signaling Mag Bead Kit-Phosphoprotein kit following the manufacture’s
protocol. Plates were read on MAGPIX with xPONENT software.
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Chapter 4: Results
4.1 Profiling male and female immune cells after infection with F. tularensis.
4.1a Analyzing immune cells responding to infection by flow cytometry
The proportion and/or activation of different immune cell populations were quantified
(Figure 9). Little difference was observed between males and females in the immune cell
populations analyzed, except for the macrophage population. A significant difference between
male and female cell population was found in the macrophages population. This difference in the
macrophage population led us to hypothesize that inflammatory M1 type macrophages might
cause the intense inflammation previously seen in female mice (Figure 4).
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Figure 9. Male and female C57BL/6 mice were infected with 1e6 cfu of F. tularensis LVS
intradermally. Spleens were harvested 3 days post-inoculation. Splenocytes were stained with
antibodies to identify various immune cell population and analyzed with the Beckman Coulter
Gallios flow cytometer. Significant differences (p<0.0001, multiple t test) between cell
population are indicated by a (*).

4.1b Determining differences in the presence of inflammatory and regulatory
macrophages between males and females
F. tularensis causes an excessive inflammatory response and elevated serum levels of
myeloid growth and differentiation factors (Figure 8) in male and female infected mice. This
significant differences between macrophages (Figure 9) between male and female led us to
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determine the ability of macrophages to produce either the cytokine IL-6 (inflammatory) or IL4 (regulatory or anti-inflammatory) macrophages. Macrophages producing these cytokines were
determined by flow cytometric intracellular cytokine staining during the peak response (72
hours) to infection. A significantly greater number of IL-6 producing macrophages was
observed in female in comparison with male mice (p=0.01, n=4; Figure 10), while no difference
was observed in IL-4 producing macrophages.
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Figure 10. A. Male and female C57BL/6 mice were infected with 1e6 cfu of F. tularensis LVS.
Spleens were harvested 3 days post-inoculation or the peak response (72 hours) to LVS
challenge. Macrophages were determined by flow cytometric staining of CD11b+ B220- cells
and intracellular cytokine staining and analyzed with the Beckman Coulter Gallios flow
cytometer B. Significant differences (p=0.01, Mann Whitney test) between male and female are
represented by a (*). (N=4).
4.1c Analyzing the inflammatory immune cells differently active in males and females
Since our data suggest that there is a significant different in the IL-6 producing
macrophages from female as compared to male, we wanted to compare the percentage of
macrophages producing IL-6 between male and female mice over the peak response (72 hours).
Significant differences between the sexes were observed at 36, 48, and 60 hours post-infection
(Figure 11). At the 36 and 48 hours post-infection time points, a greater percentage of macrophages
from female mice produced IL-6 as compared to those from male mice (p < 0.05). However, at 60
hours post-infection, a greater percentage of macrophages from male mice produced IL-6 as
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compared to those from female mice, indeed IL-6 production peaked at this time. To the contrary,
macrophages from female mice ceased to produce IL-6 at this time point. Therefore, female mice
had an earlier, faster and stronger inflammatory response as compared to male mice.
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Figure 11. Male and female C57BL/6 mice were infected with 1e6 cfu of F. tularensis LVS.
Spleens were harvested at the indicated times post-infection. Macrophages were identified as
CD11b+ B220- cells and were stained for intracellular flow cytometry and analyzed on the
Beckman Coulter Gallios flow analyzer. Significant differences (p< 0.05, multiple t test)
between male and female are indicated by a (*).

4.1d Analyzing Cytokine and chemokine analysis of males and females responding
to infection
Our data suggests that inflammatory macrophages are responding differently between
males and females possibly resulting in the difference between their sensitivity to F. tularensismediated disease. Therefore, depletion of these macrophages might eliminate the observed
sexual dimorphism. In order to deplete macrophages, we used a transgenic mouse line routinely
used as a macrophage deficient mouse strain (CD11b-hDTR). The CD11b-hDTR mouse
expresses the human diphtheria toxin receptor (DTR) under control of CD11b promoter. CD11b
is constitutively expressed in macrophages and, therefore, the human DTR is expressed in
macrophages. Upon injection of diphtheria toxin (DT) into the mice, the toxin will bind to the
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DTR and be internalized where it will induce apoptosis in those cells making the mice deficient
in macrophages.
Diphtheria toxin (15ng/g/day) was injected intraperitonially in CD11b-hDTR female and
male mice 2 days prior to infection with LVS. Diphtheria toxin administration was repeated
every other day after first dose to prevent rederivation of new macrophages from the bone
marrow. LVS was injected intradermally after the first treatment with diphtheria toxin. Female
and male mice were weighed daily, and their external body temperature was measured every day
as well for the duration of the time course. Initial experiments revealed that these mice were
much more sensitive to F. tularensis infection than wild type mice; therefore, the dose of F.
tularensis administered had to be reduced to 5e5 cfu LVS instead. Compared to wild type mice
(Figure 4), CD11b-DTR mice infected with F. tularensis showed no difference in survival
between males and female (Figure 12).
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Figure 12. Diphtheria toxin was injected intraperitonially in male and female CD11b-hDTR mice
2 days prior to infection with 5e5 cfu of F. tularensis LVS. Diphtheria toxin administration was
repeated every other day to prevent rederivation of new macrophages from the bone marrow.
LVS was injected intradermally after the first treatment with diphtheria toxin and female and
male mice were weighted daily and external temperature was measured every day as well for the
duration of time course. (n=5). No statistical difference was found by Mantel-Cox test.

Plasma samples collected from infected mice were analyzed for systemic production of
cytokines and chemokines using Milliplex assay. As opposed to the increased production of
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cytokines in wild type female mice (Figure 7), similar levels of the cytokines IFN-γ, IL-6 and
TNF were observed from female and male CD11b-DTR mice (Figure 13). Therefore, removal
of macrophages normalizes the sensitivity of males and females and their chances of survival.
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Figure 13. Male and female CD11b-hDTR mice were infected with 5e5 cfu of F. tularensis LVS.
Blood was collected retro orbital at days -1 and 3 and at termination (T) time using heparinized
capillary tubes to collect approximately 40 L of blood from each animal. Blood was processed
and plasma was collected. Plasma samples were analyzed for systemic production of cytokines
and chemokines using Milliplex assay. (N=5) No statistical difference was found by ANOVA.

4.2 Identify the mechanisms by which macrophages control susceptibility to F. tularensis.
4.2a. Determine the relative percentages of M1 vs M2 cells in males and females
Having determined that differential macrophage responses lead to different susceptibility
to disease, we next sought to determine the cellular mechanism controlling this discrepancy.
Therefore, we first analyzed differences in the presence of M1 and M2 macrophage subsets
between males and females. The percentage of M1 type macrophages was elevated in female
mice compared to that in male mice, suggesting that this difference could result in the stronger
immune response Figure 14, *p<0.005. No statistically significant difference was found in the
percentage of M2 type macrophages between the sexes.
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Figure 14. Male and female C57BL/6 mice were infected with 1e6 cfu of LVS intradermally and
spleens were harvested 3 days post-inoculation. Macrophages were identified as CD11b+ B220cells and were stained with antibodies in order to identify the macrophages subtypes (CD80 for
M1 and CD23 for M2) and analyzed on the Beckman Coulter Gallios flow cytometer. Data
represents the mean (SD). Significant differences (p<0.005, Mann Whitney test) between male
and female in M1 macrophages are indicated by a (*).

4.2b. Compare cellular response of M1 and M2 macrophages from males and
females
We next sought to determine whether the inflammatory cytokine response was different
between M1 and M2 macrophages from males and females. IL-6 produced by M1 type
macrophages in infected female’s splenocytes is higher than in infected male’s splenocytes
(p<0.0005) whereas IL-10 produced by M2 type macrophages in female cells is significantly
elevated than in male cells (p<0.001) (Figure 15). This shows a stronger immune response
against F. tularensis in females as compared to males due to higher levels of IL-6 and IL-10.
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Figure 15. Spleens from naïve male and female mice polarized using M1 or M2 cytokine
cocktails prior to infection with 1e10 cfu of F. tularensis holartica LVS. Supernatant was
collected at 48 hours post-infection and analyzed for IL-6 and IL-10 production by ELISA.
Significant differences (p<0.0005,p<0.001, multiple t-test) between male and female in IL-6
and IL-10 respectively are indicated by a (*).
Polarization was verified by analysis of the expression of iNOS (M1) using the β-Actin
housekeeping gene as a control. Figure 16 shows the fold change (2^- ΔΔCt) in iNOS in M1
and M2 type macrophages before LVS challenge. After polarization, iNOS expression in M1
polarized macrophage was elevated compared with M2 polarized macrophages in both sexes,
suggesting that the in vitro polarization was successful.
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Figure 16. A. RNA harvested from polarized macrophages was analyzed by real time RT-PCR
using iNOS primer for M1 macrophages (A) or CD206 primer for M2 macrophages (B) and
Actin β as housekeeping gene. Data is represented as fold change (2^CT).
Since LPS is used to polarize M1 macrophages and F. tularensis contains LPS, it was
possible that infected M2 macrophages could have repolarized to M1 macrophages. Therefore,
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we analyzed the expression of iNOS and CD206 48 hours post infection by real time RT-PCR.
Fold change in CD206 in infected cells for male M2 macrophages is much higher than M1
macrophages in infected cells from males. There is also an increase of CD206 in M2 from
males than in females as shown in figure 16. Showing higher levels of M2 polarized
macrophages in males suggesting that males might be protected from the cytokine storm caused
by Francisella tularensis infection.
4.2c Analyzing the different signaling pathways activated in males and females
We sought to investigate what signaling pathway was being differentially activated by
M1 and M2 male and female macrophages infected with F. tularensis LVS. These kits measure
the total and phosphorylated proteins of 9 different transcription factor allowing us to determine
the activation of different cellular pathways. Based on our results, CREB and ERK 1/2 activation
index was statistically different between males and females, particularly for ERK 1/2. M1 type
macrophage from females have a higher activation of ERK 1/2 compared with M1 type
macrophages from males (figure 18). ERK 1/2 activation has been associated with polarization
of toward the M1 type macrophages. We concluded that the higher ERK 1/2 activation in
females results in more proinflammatory macrophages compared with males; therefore, secreting
more IL-6 and eliciting greater inflammation (Figure 15).
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Figure 18. In vitro polarized macrophages infected with LVS were lysed in buffer containing
protease inhibitor cocktail and phosphatase inhibitor. The lysates were analyzed using a 9-plex
Multi-Pathway Total Magnetic Bead Kit and 9-Plex Multi-Pathway Signaling Mag Bead KitPhosphoprotein multiplex ELISA kit. Significant differences (*p<0.05 and **p<0.005, twoway ANOVA) were observed between male and female macrophages.
In contrast, ERK 1/2 activation in M2 type macrophages was significantly higher in males
than in females (Figure 19). It has been suggested that activation of ERK 1/2 in macrophages
triggers the secretion of more IL-10 whereas, if ERK 1/2 is inhibited, there is more production
of pro-inflammatory cytokines such as IL-12 [52]. The high activation of ERK 1/2 seen in male
M2 type macrophages could be support this finding where the higher activation of ERK 1/2
produces more IL-10. Therefore, males are better protected from detrimental consequences of
LVS.
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Figure 19. In vitro polarized macrophages infected with LVS were lysed in buffer containing
protease inhibitor cocktail and phosphatase inhibitor. The lysates were analyzed using a 9-plex
Multi-Pathway Total Magnetic Bead Kit and 9-Plex Multi-Pathway Signaling Mag Bead KitPhosphoprotein multiplex ELISA kit. Significant differences (**p<0.005, two-way ANOVA)
were observed between male and female macrophages.
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Chapter 5: Discussion and future work
Males and females differ in susceptibility to various infectious diseases, with males being
more susceptible to infectious diseases [40].This is attributed to males generally exhibiting lower
immune responses than females [40] [53].
Our data suggests that females are more susceptible to F. tularensis infection in comparison
to males due to their stronger and more rapid immune response. Although it has been demonstrated
that females are less susceptible to the development of bacterial infections following bacteremia
or sepsis, males show greater incidence and severity of bacterial infections and they are far more
likely to develop lethal consequences [54]. In several mycobacterial infections, including M.
lepraemurium, M. marinum and M. intracellulare, male mice were more susceptible to infection
[42]. In M. intracellulare infection in mice, males had more severe gross lesions in the visceral
organs as wells as increased numbers of microbes in the lungs, liver and spleen compared with
females. Examination of peritoneal macrophages from male mice infected with M. intracellulare
showed more rapid growth of phagocytosed organisms suggesting that female peritoneal
macrophages possess more potent antibacterial activity [42].
In our study, we showed that C57BL/6 female mice infected with LVS do poorly to
infection and consequently infection is detrimental as compared to males. Importantly and distinct
from other infectious diseases, an excessive inflammatory response resulting in a sepsis like
response is a key feature of death from F. tularensis [55]. Differences in the production of proinflammatory cytokines between sexes might therefore have a lethal consequence [54]. Female
mice infected with F. tularensis showed an increase in serum levels of pro-inflammatory cytokines
such as IL-6, IL-1, and TNF. It has been demonstrated that development of sepsis is mainly
driven by the overproduction of these cytokines [53]. Septic shock is mediated mostly by the
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activation of macrophages and the subsequent overproduction of pro-inflammatory mediators [54].
Our study showed a difference between the involvevement of two phenotypes of macrophage,
where females exhibited higher levels of inflammatory macrophage subtype (M1) as compared to
males.
Since females tend to mount higher innate, cell mediated and humoral immune responses
than males, elevated immunity in female represents a balance between immune responses
conferring protection and causing pathology [56]. Several studies showed that excessive proinflammatory responses known as a cytokine storm contribute drastically to morbidity and
mortality [56]. Our study shows that females mount a higher cytokine storm mainly elicited by
pro-inflammatory subtype macrophage (M1). We found that there is a higher percentage of M1
type macrophages activated females responding to F. tularensis infection than in males, likely
leading to the elevated cytokine storm.
It has been suggested that macrophage depletion might enhance survival by removing the
bacterial (F. tularensis) replication location [55]. Our data showed that when macrophages are
depleted the level of pro-inflammatory cytokines IFN-γ, IL-6 and TNF were normalized between
the sexes suggesting that infected macrophages where the source of the differential cytokine
response. This data suggested that removal of macrophages would improve the chances of survival
in female mice. Indeed, while mice depleted of macrophages were more sensitive to infection, the
sex differences where ablated.
In vitro studies where peritoneal macrophages were used, it was shown that cells from male
mice produce higher levels of IL-6 following LPS challenge than similarly treated cells from
females [57]. However, in our study in vitro studies demonstrated that macrophages from females
produce higher levels of IL-6 following LVS challenge than cells from males. In addition, we have
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demonstrated that females macrophages secrete higher levels of anti-inflammatory cytokine IL-10
than do macrophages from males as it has been shown previously in another studies [58]. Studies
reveal that higher pro-inflammatory responses are correlated with mortality during infection, as
seen in our study [56]. These discrepancies are likely due to differential signaling and activation
of macrophages responding to varying stimuli. Specifically, macrophages responding to F.
tularensis infection primarily activated the CREB and ERK 1/2 signaling pathways.
Overall, elevated immunity among females creates a double edge sword which might be
beneficial against infectious disease but also might be detrimental in terms of risk of developing
an autoimmune diseases [49]. We demonstrated that a stronger and faster immune response elicited
by M1 type macrophage is detrimental against F. tularensis in female mice whereas in male mice
there is no lethal consequence.
Studies have shown that IFN-γ is essential for survival from respiratory F. tularensis
infections and alveolar macrophages are required for protection against infectious doses with the
microorganism [54]. Based on this, future work might include testing androgen functions as this
sex steroid hormones differentially impact the outcome of influenza A virus infection in mice.
Influenza A dysregulates cytokine and chemokine production in females, causing significantly
more susceptibility to weight loss, hypothermia and death as compared to males [56]. In that same
study, administration of high dose of estradiol or an estrogen receptor  (ER) antagonist
suppresses the production of cytokines and chemokines and increases survival following viral
infection [56].
In addition, neutrophils have shown to be essential for survival of intravenous or
intradermal F. tularensis infection. However, it has been suggested that neutrophils are detrimental
to the host following pulmonary F. tularensis infection due to induction of overwhelming
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inflammation [55]. Indeed, this secondary tropism may explain the lethality seen in the absence of
macrophages. Future studies may investigate the role of neutrophils by depleting them and see the
cellular response, production of pro-inflammatory cytokines and survival within sexes.
As stated, LPS and LVS stimulation of macrophages resulted in opposite responses of
cytokine production. Since LVS stimulates TLR-2 (while LPS stimulates LPS), it would be ideal
to look at that pathway in better detail such as downstream targets of ERK 1/2 pathway. Previous
studies with M. tuberculosis, which activates TLR-2 signaling pathway, demonstrated that
activation of ERK promotes secretion of IL-10 and decreases secretion of IL-12. On the contrary,
inhibition of ERK decreases secretion of IL-10 while increases secretion of IL-12. However, there
are conflicting reports on the polarizing activity of ERK which promotes polarization from M2 to
M1 macrophages enhancing IL-12 and IFN- production [52, 59]. Specifically identifying the
signaling pathway(s) involved in this differential and opposite response thereby remains a
challenge to be addressed.
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